DJIA 16,014.38 -12.67 -0.08%
NASDAQ 4,268.76 -14.99 -0.35%
S&P 500 1,852.21 -1.23 -0.07%
market minute promo

1.89 0.11 (6.18%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

BCRX $1.89 6.18%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.79
Previous Close $1.78
Daily Range $1.78 - $2.09
52-Week Range $1.76 - $16.83
Market Cap $138.6M
P/E Ratio -3.56
Dividend (Yield) $0.00 (0.0%)
Volume 4,916,220
Average Daily Volume 1,061,859
Current FY EPS -$0.61

Sector

Healthcare

Industry

Drug Makers

BioCryst Pharmaceuticals, Inc. (BCRX) Description

A biotechnology company, which designs, optimizes and develops novel drugs that block key enzymes involved in cancer, cardiovascular diseases, autoimmune diseases, and viral infections. Website: http://www.biocryst.com/

News & Commentary

Here's Why Shares of BioCryst Pharmaceuticals, Inc. Are Falling Today

Despite a positive clinical outcome for BioCryst's experimental treatment for hereditary angioedema, the biotech's shares are falling hard today. Here's why.

Company News for February 09, 2016

BioCryst (BCRX) Stock Downgraded at Jefferies

Health Care Sector Update for 02/09/2016: AGTC, BCRX

Benzinga's Top Downgrades

BioCryst Hit With A HAE-Maker

BioCryst Downgraded By JPMorgan, Analysts Await 'More Data'

Biocryst's Setback: An Opportunity For Brave Investors

BioCryst (BCRX) Stock Plummets on Disappointing Trial Results

Mid-Afternoon Market Update: Crude Oil Down 3%; Biocryst Pharmaceuticals Shares Drop Following Annou

Mid-Afternoon Market Update: Crude Oil Down 3%; Biocryst Pharmaceuticals Shares Drop Following Announcement of Failed Avoralstat Trial Results

Mid-Afternoon Market Update: Crude Oil Down 3%; Biocryst Pharmaceuticals Shares Drop Following Annou

Mid-Afternoon Market Update: Crude Oil Down 3%; Biocryst Pharmaceuticals Shares Drop Following Announcement of Failed Avoralstat Trial Results

See More BCRX News...

BCRX's Top Competitors

BCRX $1.89 (6.18%)
Current stock: BCRX
AMGN $143.16 (0.11%)
Current stock: AMGN
GILD $87.25 (2.33%)
Current stock: GILD
BIIB $249.99 (-0.31%)
Current stock: BIIB